noom glp-1 microdose reviews Unboxing GLP-1ᴿˣ | My Weight Loss Journey Microdosing GLP-1 for Weight Loss:

On average, clinical studies have shown that individuals can expect to lose between 4-10% of their body weight within the first few months of treatment

FDA-Noted Concerns: Increased heart rate Systemic vasodilatory reactions Limited clinical safety data Immunogenicity risk (antibody formation) Reported Side Effects: Injection site reactions (redness, swelling, itching) Headache Flushing Dizziness Nausea Water retention Serious Concerns: Potential for glucose metabolism disruption Theoretical cancer risk (GH/IGF-1 promote cell proliferation) Long-term safety unknown Regulatory Status United States: CJC-1295 is not FDA approved for any indication

This leads many users to feel like the supplement is enabling them to get a better workout

Insights from a mediation analysis of the EMPA-REG OUTCOME trial

It is the safest and most effective, and its very cost effective and has very little downtime or impact on your lifestyle